JavaScript is disabled on your browser. The site is not fully functional . To use the services of this site, Turn JavaScript .
EPS mechanically benefit from the excellent 2021 execution. Looking into 2022 and 2023, the order book and tight management should help digest fast-rising costs as long as the top line remains in positive territory.
The target price benefits from extremely solid 2021 execution that has provided a higher base looking forward. We have injected a degree of caution on the outlook from H2-2022 even though the activity target (€600m sales) within reach.
The NAV benefits from repeated strong realisations that combine with higher market multiples on similar businesses
